Podcasts about Uppsala University

What happens when a bishop breaks with Rome but still claims apostolic succession? Damian Thompson is joined by historian Magnus Lundberg, Professor of Church and Mission History at Uppsala University in Sweden, to explore the strange world of ‘wandering bishops', rival popes and tiny schismatic churches. They trace the tangled web of consecrations that have produced thousands of bishops outside the authority of Rome, and explore the grandiose titles and ceremonies of these independent bishops. They also examine the roots of sedevacantism, the legacy of Archbishop Lefebvre and the Society of St Pius X, and ask whether the latest breakaway bishops could create yet another schism. Plus, where exactly does the Catholic Church draw a line between a bishop whose orders are illicit and one whose orders are invalid? Produced by Patrick Gibbons.Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.For more Spectator podcasts, go to spectator.co.uk/podcasts. Contact us: podcast@spectator.co.uk Hosted on Acast. See acast.com/privacy for more information.

What happens when a bishop breaks with Rome but still claims apostolic succession? Damian Thompson is joined by historian Magnus Lundberg, Professor of Church and Mission History at Uppsala University in Sweden, to explore the strange world of ‘wandering bishops', rival popes and tiny schismatic churches. They trace the tangled web of consecrations that have produced thousands of bishops outside the authority of Rome, and explore the grandiose titles and ceremonies of these independent bishops. They also examine the roots of sedevacantism, the legacy of Archbishop Lefebvre and the Society of St Pius X, and ask whether the latest breakaway bishops could create yet another schism. Plus, where exactly does the Catholic Church draw a line between a bishop whose orders are illicit and one whose orders are invalid? Produced by Patrick Gibbons. Hosted on Acast. See acast.com/privacy for more information.

In fact, most dinosaurs never got the chance to stop and smell a flower... and it was all because of bad timing. Sad face.The meteor that killed all the dinosaurs (rude) actually kicked off flower supremacy on planet earth. Flowering plants are only about 135 million years old, yet they're the most bio-diverse plants on the planet. Without them, no birds, no bees. Again, sad face. So where did flowers come from? And how did they end up being top bud?  FEATURING: Mario Vallejo-Marin - Professor in Evolutionary Ecology, Uppsala University, Sweden.Professor Michelle Waycott - Chief Botanist at the Adelaide Botanic Gardens State Herbarium / Professor in Systematic Biology, Adelaide University.Morris Lake - Author, Australian Rainforest Woods.Gareth Prosser - Professional Voice Over Artist whose wife roped him in. PRODUCTION:Ann Jones, Presenter / ProducerSarah Prosser, ProducerMastering Engineer: Tegan NichollsThis episode of What the Duck was produced on the land of the Wadawurrung people. Find more episodes of the ABC podcast, What the Duck?! with the always curious Dr Ann Jones exploring the mysteries of nature on ABC Listen (Australia) or wherever you get your podcasts. You'll learn more about the weird and unusual aspects of our natural world in a quirky, fun way with easy to understand science.

Have you ever wondered how a child's ability to manage their emotions and impulses might shape their later mental health? And, what if one of the most important predictors isn't about how clever they are, but how well regulated they are on the inside? This episode of the Mind the Kids podcast features Lilja Jónsdóttir, a PhD student at the Department of Psychology at Uppsala University, Sweden, who will shortly take up a postdoctoral research position in child and adolescent psychiatry at Uppsala's Department of Medical Sciences. Hosted by Mark Tebbs, the conversation explores her paper, Examining Early Inhibitory Control and Emotional Regulation as Predictors of Childhood Internalizing and Externalizing Problems: A Longitudinal Study, co-authored with her supervisor Professor Karen Brocki, co-supervisors Dr. Matilda Frick and Dr. Andreas Frick of Stockholm University, and fellow PhD researcher Emma Heemann.The discussion unpacks the hierarchical development of self-regulation, examining how simpler skills such as inhibitory control — the ability to override an automatic impulse, illustrated through the classic marshmallow test — feed into more complex abilities like emotion regulation. Drawing on data from the long-running Effect Project, a longitudinal study following 94 typically developing children in Uppsala from infancy, Lilja explains how inhibitory control was measured at age four using the day-night Stroop task, emotion regulation was assessed at age six via validated parent-report measures, and internalizing and externalizing problems were captured at nine to ten years using the Strengths and Difficulties Questionnaire.Contrary to prior research and theoretical expectations, the study found no link between early inhibitory control and later emotion regulation or behavioural outcomes. Instead, emotion regulation at age six emerged as a robust, transdiagnostic predictor of both internalizing problems (such as worry and withdrawal) and externalizing problems (such as impulsivity and defiance) three to four years later — a finding that held even within a relatively advantaged community sample, strengthening the case for universal, early support.This conversation is essential listening for clinicians, educators, and parents interested in child development, self-regulation, and early intervention. Lilja discusses the importance of co-regulation between caregivers and children, promising directions for emotion-regulation-focused support, and why publishing null results — such as the absence of an inhibitory control effect here — matters for advancing the field.Read the JCPP Advances paper 'Examining early inhibitory control and emotion regulation as predictors of childhood internalizing and externalizing problems: A longitudinal study'Lilja K. Jónsdóttir, Matilda A. Frick, Andreas Frick, Emma J. Heeman, Karin C. BrockiFirst published: 07 January 2026 https://doi.org/10.1002/jcv2.70093Get a free CPD/CME certificate for listening to this podcast by registering for a FREE ACAMH Learn account at https://bit.ly/4fF4BBWVisit https://www.acamh.orgFacebook and LinkedIn search / ACAMHInstagram https://www.instagram.com/assoc.camhBluesky https://bsky.app/profile/acamh.bsky.socialX https://x.com/acamh

Welcome back to the Audible Bleeding Series: Landmark Papers in Vascular Surgery. In this episode, Audible Bleeding editor John Culhane and co-host Dr. Jesse Columbo are joined by our guests, Dr. David Stone, Dr. Salvatore Scali, and Dr. Anders Wanhainen to unpack one of the longest-running debates in aortic surgery: when (and whether) to repair an abdominal aortic aneurysm. We'll start our episode with the open-repair era and the two trials that set the basis for the 5.5 cm threshold—UKSAT and ADAM—then move into the early EVAR years with PIVOTAL and CAESAR, which asked whether fixing smaller aneurysms with endovascular technology could do better. Finally, we'll look at how modern screening programs, improved medical therapy, and current guidelines have reshaped the practical decisions we make for these patients every day.   Links to Papers Discussed: Open Surgery Era 1.    UKSAT (1998) 2.    ADAM (2002)    Endovascular Era 1.    PIVOTAL (2010) 2.    CAESAR (2012)    Contemporary Results 1.    Oliver-Williams/NHS NAAASP  2.    Rokosh/SVS Guidelines 3.    ESVS 2026 Guidelines   Guests: Dr. David Stone, MD (@DHStoneMD); Dartmouth Dr. Salvatore Scali, MD (@UFVascular); University of Florida Dr. Anders Wanhainen, MD, PhD (@AWanhainen); Uppsala University, Sweden   Hosts: John Culhane, MD (@JohnCulhaneMD); Vascular Surgery Fellow, Montefiore Dr. Jesse Columbo, MD; Dartmouth   Follow us @audiblebleeding,   Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Guests:Charlotte Blease, Philosopher at Uppsala University and author of ‘Dr Bot: Why Doctors Can Fail Us – and How AI Could Save Lives'Kevin Mitchell, Associate Professor of Genetics and Neuroscience at Trinity College Dublin and author of ‘Free Agents – How Evolution Gave Us Free Will'Alan Smeaton, Professor of Computing at DCUMatthew Campbell from TCDLaura Hayes, DIAS

Hot humid/smoky heat domes over E. North America, UK, and Europe. Scientist Michael Mann blames changed planetary waves. Gabriele Messori, Uppsala University: “whiplash” combined climate hazards are increasing. Our body's heat tolerance is lower than we were told. Dr. Daniel Vecellio on “Greatly  …

What happens to your data when you die?   In this episode of Data Malarkey, Master Data Storyteller, Sam Knowles, welcomes Carl Öhman, Assistant Professor in Political Science at Uppsala University and author of The Afterlife of Data: What Happens to Your Information When You Die and Why You Should Care.   Carl explores one of the most overlooked questions in the digital age: what becomes of the vast trail of data we all leave behind, and who gets to control it once we are gone. From history, archives, and memory to big tech business models, digital afterlife products, environmental costs, and the politics of forgetting, this is a rich and thought-provoking conversation about the future of our digital remains.   In this episode, you'll learn: Why the data we leave behind after death is a major political and ethical issue Why our so-called digital "trash" may become one of the richest archives in human history How social and digital media platforms are building unprecedented records of human behaviour Why digital afterlife products raise unsettling questions about grief, memory, and authenticity What happens when dead users start to outnumber living users on platforms like Facebook Why big tech has powerful incentives to keep hold of the data of the dead Whether regulation should include a kind of "right to be forgotten" after death - a "posthumous GDPR" Why data storage and environmental cost matter in debates about digital remains How AI and data may be creating something like a new digital theology   Topics we cover: Carl's route into studying death and digital traces Digital dandruff, archives, and the value of informational leftovers Ownership, memory, and the politics of historical record The future of historical research in a world of platform-controlled archives Black Mirror, digital resurrection, and the digital afterlife industry Big tech incentives and "holding our loved ones hostage" Regulation, GDPR, and who should guard the guards The carbon footprint of storing dead people's data Carl's next book, on AI: The Gods of Data   About our guest: Carl Öhman is Assistant Professor in Political Science at Uppsala University. His research focuses on the politics and ethics of AI, digital memory, and the governance of information. He is the author of The Afterlife of Data and works at the intersection of technology, politics, and culture. Links and resources mentioned: The Afterlife of Data by Carl Öhman - https://press.uchicago.edu/ucp/books/book/chicago/A/bo209942751.html Carl's page at Uppsala University - https://bit.ly/4tIeXHX Take the Data Storytelling Scorecard: https://data-storytelling.scoreapp.com  

Transformers podcast with Christina Lampe-Önnerud — founder and CEO of Cadenza Innovation, PhD from Uppsala University, post doctoral researcher at MIT. The post Meet Christina Lampe-Önnerud, The US-Based Battery Queen from Sweden first appeared on Kaj Embren.

In this episode, Peter sits down with Ulf Landegren, Professor of Molecular Medicine at Uppsala University and a pioneer in DNA-based detection technologies.Ulf shares the story behind one of his lab's most important breakthroughs, rolling circle amplification, and how it almost didn't happen when a student pushed ahead despite his doubts.He also explores how this technology has evolved into powerful methods for detecting cancer mutations with extraordinary sensitivity, offering new ways to monitor disease and patient outcomes, particularly in leukemia.Along the way, Ulf reflects on the human side of science—from the role of curiosity and persistence in discovery to lively (and very vocal) scientific debates with his son on family bike rides.Watch or listen to all episodes of Flow Stars: flowstars.bitesizebio.com

I'd love to hear your thoughts, feedback and insights on what could improve The ADHD Women's Wellbeing Podcast in this short poll - it takes 2 minutes, and as a thank you, we'll send you a little gift!How many times have you walked into a doctor's appointment knowing something is wrong, and walked out feeling dismissed, unheard, or handed an explanation that just doesn't fit?For women with ADHD, the intersection of hormones and neurodivergence has been one of medicine's most neglected areas. Not because it isn't important, but because for too long, women have been considered too complex, too variable, too messy to study properly. And the cost of that has been devastating.This week on The ADHD Women's Wellbeing Podcast, I'm welcoming back Dr Lotta Borg Skoglund, a psychiatrist, researcher, and Associate Professor at Uppsala University in Sweden. Lotta has spent years investigating how hormonal fluctuations shape ADHD across women's entire reproductive lives — and her new book, Female Hormones and ADHD: The Impact on Brain and Body, is out in the UK on 4th June.What Lotta shares in this episode is not just fascinating; it is information that women deserve to have, and that could genuinely change their long-term health.In this episode, we explore:Why women have historically been excluded from research, and what that has cost us clinicallyLotta's new research on ADHD medication during pregnancy, lactation, and across the menstrual cycleWhy neurodivergent women may experience perimenopause symptoms earlier, and why this so often goes unrecognisedThe critical window of opportunity for hormone therapyWhy a hormonal assessment should come before receiving ADHD medicationThe link between postmenopausal oestrogen loss and heart attacks in womenThe connections between ADHD and endometriosis, PCOS, burnout, pain and sick leaveWhy every doctor (regardless of specialism) needs to be asking about hormonesHow we can use the predictable hormonal risk windows across a woman's reproductive life to support herTestosterone, perimenopause, and what the research does and doesn't yet tell usHow Lotta's new book can help you advocate for yourself in the doctor's officeThis episode is for every woman who has ever felt that her hormonal health and her neurodivergence were being treated as two completely separate problems by two completely separate systems.Lotta's work is quietly changing what is possible for us, and this conversation is essential listening.You can also listen to our previous conversations with Lotta here:E120 Connecting Hormones and Psychiatry to help more ADHD womenE174: Breaking down ADHD Neuroscience, Menstrual Cycles, Hormones and AnxietyThis week's episode is sponsored by Understood.org, the leading nonprofit dedicated to empowering the millions of people with learning and thinking differences, like ADHD and dyslexia.If you're parenting a neurodivergent child, I'd recommend listening to their podcast, Everybody Gets a Juicebox, as it's full of relatable stories and practical tools to help your family thrive while protecting your own wellbeing, too!The ADHD Women's Wellbeing Live Event Recording is here!My first-ever ADHD Women's Wellbeing Live event sold out, and now the full experience is available to you wherever you are, whenever it feels right.Alongside three neuro-affirming experts, we spent four hours exploring the questions that matter most to late-diagnosed women. Get lifetime access here!Inside the ADHD Women's Wellbeing Live Recording, you'll find:Kate Moryoussef on post-diagnosis growth and her gentle framework for what comes nextDr Hannah Cullen on the neuroscience of ADHD and why your brain works the way it doesHannah Miller on reconnecting with purpose through a neurodivergent lensAdele Wimsett myth-busting on hormones, HRT, progesterone and perimenopauseUnderstand yourself more deeply, feel less alone, and finally access the expert knowledge you deserve. Because every woman with ADHD deserves access to the knowledge, expertise and understanding that for too long simply hasn't been available to us.To get lifetime access for £44, click here.Links and Resources:Find my popular ADHD workshops and resources on my website [here].Follow the podcast on Instagram: @adhd_womenswellbeing_podVisit Lotta's website (lottaborgskoglund.com) for more informationKate Moryoussef is a women's ADHD lifestyle and wellbeing coach and EFT practitioner who helps overwhelmed and unfulfilled newly diagnosed ADHD women find more calm, balance, hope, health, compassion, creativity and clarity.

As we mark the 200th episode of the Leaders in Finance Podcast, we are honoured to welcome Mikael Björknert. Mikael Björknert became CEO of PrivatBank on 20 January 2025. He now leads Ukraine's largest state owned bank, serving more than 18 million active customers, with over 70% of Ukrainians using its services.  He brings more than 25 years of experience in the financial sector. Before taking the helm at PrivatBank in Kyiv, he held several senior leadership positions at Swedbank, including Head of Swedish Banking, where he was responsible for one of the bank's core business areas. He also served as Chairman of Bankgirot and as a board member of Nasdaq in Sweden.  Mikael holds a Bachelor of Business Administration from Uppsala University. He is 59 years old, lives in Kyiv, and is married with two children.    *** Leaders in Finance is made possible by the support of EY, Mogelijk Vastgoedfinancieringen, and Lepaya. More information about our partners is available at our partner page.   *** Books mentioned in this episode: The Gates of Europe, Serhii Plokhy   *** Want to stay up to date with Leaders in Finance? Subscribe to the newsletter.   *** Questions, suggestions, or feedback? We'd love to hear from you! You can reach us via email at info@leadersinfinance.nl and check out our website.   *** Previous guests on the Leaders in Finance podcast include:  Klaas Knot (President DNB), Frank Elderson (Executive Board, ECB), Roland Boekhout (CEO ASN Bank), Gerrit Zalm (former Minister of Finance and former CEO of ABN AMRO),  Ingrid de Swart (member of the Executive Board, a.s.r.), Pinar Abay (Management Board ING, Head of Retail Banking), Robert Swaak (CEO ABN AMRO), Marcel Zuidam (CEO NN Bank), Saul van Beurden (CEO Consumer, Small & Business Banking, Wells Fargo), David Knibbe (CEO NN Group), Janine Vos (Executive Board, Rabobank), Nadine Klokke (CEO Knab), Maarten Edixhoven (CEO Van Lanschot Kempen), Jeroen Rijpkema (CEO Triodos Bank), Nout Wellink (former President DNB), Onno Ruding (former minister of finance), Yoram Schwarz (CEO Movir), Laura van Geest (Executive Board, AFM),  Katja Kok (CEO Van Lanschot CH), Ali Niknam (CEO bunq), Nick Bortot (CEO BUX), Petri Hofsté (supervisory board member, including at Rabobank and Achmea), Peter Paul de Vries (CEO Value8), Barbara Baarsma (CEO Rabo Carbon Bank), Jan van Rutte (C supervisory board member, including at Rabobank and Achmea), Marguerite Soeteman-Reijne (Chair Aon Holdings), Lidwin van Velden (CEO Nederlandse Waterschapsbank), Jan-Willem van der Schoot (CEO Mastercard NL), Joanne Kellermann (Chair PFZW), Steven Maijoor (former Chair ESMA), Radboud Vlaar (CEO Finch Capital), Jos Baeten (CEO a.s.r.), Karin van Baardwijk (CEO Robeco), Annette Mosman (CEO APG).   

Guest: Charlotte Blease, Associate Professor in the Department of Women's and Children's Health, Uppsala University, Sweden and Author of ‘Dr Bot: Why Doctors Can Fail Us – and How AI Could Save Lives'.

Gender is becoming a central battleground in contemporary authoritarian politics, but how do autocrats manipulate these debates to their own advantage? Some regimes now pursue a double strategy of simultaneous “gender bashing” and “gender washing”: mobilising anti-gender rhetoric and “traditional values” to attack feminists and roll back equality, while at the same time promoting loyal women into prominent roles to project an image of modernity, reform, and inclusion at home and abroad. By combining repression with reputation laundering, they mask authoritarian practices and complicate the struggle for genuine gender equality. Join the People, Power, Politics podcast as we talk to Elin Bjarnegård and Pär Zetterberg about their latest Journal of Democracy article and explore how this mix of gender bashing and gender washing is reshaping the fight for equal rights and democratic politics. Guest: Elin Bjarnegård is a Professor of Political Science at Uppsala University specialising in gender and politics, political violence, and authoritarianism. Her research explores how gender norms shape political institutions and how formal and informal rules affect women's political representation. She has written extensively on gendered power structures, clientelism, and the strategic manipulation of equality reforms. A leading scholar in the field, Bjarnegård's work has been published in major academic journals and contributes to our understanding of how gender dynamics intersect with democratic decline and political reform. Pär Zetterberg is a Professor of Political Science at Uppsala University specialising in elections, political representation, and democratic institutions. His research examines gender quotas, electoral systems, and the conditions under which institutional reforms strengthen or undermine democratic accountability. He has published widely on women's political representation and the effects of electoral rules on inclusion and governance. Through his academic and policy engagement, Zetterberg has advanced debates on how representation can both support and be instrumentalised within contemporary political systems. Presenter: Dr Nic Cheeseman is the Professor of Democracy and International Development at the University of Birmingham and Founding Director of CEDAR. The People, Power, Politics podcast brings you the latest insights into the factors that are shaping and re-shaping our political world. It is brought to you by the Centre for Elections, Democracy, Accountability and Representation (CEDAR) based at the University of Birmingham, United Kingdom. Join us to better understand the factors that promote and undermine democratic government around the world and follow us on Twitter at @CEDAR_Bham! Transcript here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Gender is becoming a central battleground in contemporary authoritarian politics, but how do autocrats manipulate these debates to their own advantage? Some regimes now pursue a double strategy of simultaneous “gender bashing” and “gender washing”: mobilising anti-gender rhetoric and “traditional values” to attack feminists and roll back equality, while at the same time promoting loyal women into prominent roles to project an image of modernity, reform, and inclusion at home and abroad. By combining repression with reputation laundering, they mask authoritarian practices and complicate the struggle for genuine gender equality. Join the People, Power, Politics podcast as we talk to Elin Bjarnegård and Pär Zetterberg about their latest Journal of Democracy article and explore how this mix of gender bashing and gender washing is reshaping the fight for equal rights and democratic politics. Guest: Elin Bjarnegård is a Professor of Political Science at Uppsala University specialising in gender and politics, political violence, and authoritarianism. Her research explores how gender norms shape political institutions and how formal and informal rules affect women's political representation. She has written extensively on gendered power structures, clientelism, and the strategic manipulation of equality reforms. A leading scholar in the field, Bjarnegård's work has been published in major academic journals and contributes to our understanding of how gender dynamics intersect with democratic decline and political reform. Pär Zetterberg is a Professor of Political Science at Uppsala University specialising in elections, political representation, and democratic institutions. His research examines gender quotas, electoral systems, and the conditions under which institutional reforms strengthen or undermine democratic accountability. He has published widely on women's political representation and the effects of electoral rules on inclusion and governance. Through his academic and policy engagement, Zetterberg has advanced debates on how representation can both support and be instrumentalised within contemporary political systems. Presenter: Dr Nic Cheeseman is the Professor of Democracy and International Development at the University of Birmingham and Founding Director of CEDAR. The People, Power, Politics podcast brings you the latest insights into the factors that are shaping and re-shaping our political world. It is brought to you by the Centre for Elections, Democracy, Accountability and Representation (CEDAR) based at the University of Birmingham, United Kingdom. Join us to better understand the factors that promote and undermine democratic government around the world and follow us on Twitter at @CEDAR_Bham! Transcript here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies

Gender is becoming a central battleground in contemporary authoritarian politics, but how do autocrats manipulate these debates to their own advantage? Some regimes now pursue a double strategy of simultaneous “gender bashing” and “gender washing”: mobilising anti-gender rhetoric and “traditional values” to attack feminists and roll back equality, while at the same time promoting loyal women into prominent roles to project an image of modernity, reform, and inclusion at home and abroad. By combining repression with reputation laundering, they mask authoritarian practices and complicate the struggle for genuine gender equality. Join the People, Power, Politics podcast as we talk to Elin Bjarnegård and Pär Zetterberg about their latest Journal of Democracy article and explore how this mix of gender bashing and gender washing is reshaping the fight for equal rights and democratic politics. Guest: Elin Bjarnegård is a Professor of Political Science at Uppsala University specialising in gender and politics, political violence, and authoritarianism. Her research explores how gender norms shape political institutions and how formal and informal rules affect women's political representation. She has written extensively on gendered power structures, clientelism, and the strategic manipulation of equality reforms. A leading scholar in the field, Bjarnegård's work has been published in major academic journals and contributes to our understanding of how gender dynamics intersect with democratic decline and political reform. Pär Zetterberg is a Professor of Political Science at Uppsala University specialising in elections, political representation, and democratic institutions. His research examines gender quotas, electoral systems, and the conditions under which institutional reforms strengthen or undermine democratic accountability. He has published widely on women's political representation and the effects of electoral rules on inclusion and governance. Through his academic and policy engagement, Zetterberg has advanced debates on how representation can both support and be instrumentalised within contemporary political systems. Presenter: Dr Nic Cheeseman is the Professor of Democracy and International Development at the University of Birmingham and Founding Director of CEDAR. The People, Power, Politics podcast brings you the latest insights into the factors that are shaping and re-shaping our political world. It is brought to you by the Centre for Elections, Democracy, Accountability and Representation (CEDAR) based at the University of Birmingham, United Kingdom. Join us to better understand the factors that promote and undermine democratic government around the world and follow us on Twitter at @CEDAR_Bham! Transcript here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/political-science

Gender is becoming a central battleground in contemporary authoritarian politics, but how do autocrats manipulate these debates to their own advantage? Some regimes now pursue a double strategy of simultaneous “gender bashing” and “gender washing”: mobilising anti-gender rhetoric and “traditional values” to attack feminists and roll back equality, while at the same time promoting loyal women into prominent roles to project an image of modernity, reform, and inclusion at home and abroad. By combining repression with reputation laundering, they mask authoritarian practices and complicate the struggle for genuine gender equality. Join the People, Power, Politics podcast as we talk to Elin Bjarnegård and Pär Zetterberg about their latest Journal of Democracy article and explore how this mix of gender bashing and gender washing is reshaping the fight for equal rights and democratic politics. Guest: Elin Bjarnegård is a Professor of Political Science at Uppsala University specialising in gender and politics, political violence, and authoritarianism. Her research explores how gender norms shape political institutions and how formal and informal rules affect women's political representation. She has written extensively on gendered power structures, clientelism, and the strategic manipulation of equality reforms. A leading scholar in the field, Bjarnegård's work has been published in major academic journals and contributes to our understanding of how gender dynamics intersect with democratic decline and political reform. Pär Zetterberg is a Professor of Political Science at Uppsala University specialising in elections, political representation, and democratic institutions. His research examines gender quotas, electoral systems, and the conditions under which institutional reforms strengthen or undermine democratic accountability. He has published widely on women's political representation and the effects of electoral rules on inclusion and governance. Through his academic and policy engagement, Zetterberg has advanced debates on how representation can both support and be instrumentalised within contemporary political systems. Presenter: Dr Nic Cheeseman is the Professor of Democracy and International Development at the University of Birmingham and Founding Director of CEDAR. The People, Power, Politics podcast brings you the latest insights into the factors that are shaping and re-shaping our political world. It is brought to you by the Centre for Elections, Democracy, Accountability and Representation (CEDAR) based at the University of Birmingham, United Kingdom. Join us to better understand the factors that promote and undermine democratic government around the world and follow us on Twitter at @CEDAR_Bham! Transcript here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/world-affairs

In today's world, it is almost impossible to go through the day without interacting with a bank—whether through a salary payment, a debit card, a credit card, or a digital ID used to access public services online. Yet this intimate relationship between households and banks is relatively recent. In this episode of the New Books Network, I speak with Orsi Husz, Professor at Uppsala University, about her book Bankminded: Banks as Intimate Agents of Everyday Life in Welfare State Sweden. The book traces how, from the late 1950s onwards, banks gradually became embedded in the everyday routines of ordinary people. Through wage accounts, credit cards, financial advice, and identity documents, financial institutions reshaped how households handled money—and how they thought about finance itself. Drawing on rich archival research, Husz shows that this transformation was not simply a story of technology or markets. It involved cultural shifts around class, gender, morality, and identity, as well as the surprising role of the welfare state in expanding everyday banking. The result was what she calls the “bankification” of everyday life—a process that laid the groundwork for the financialised world we inhabit today. If you are interested in the history of banking, the culture of finance, or how modern financial habits emerged, this conversation offers a fascinating perspective on a transformation that most of us now take for granted. You can download the book for free (Open Access) here Listen to the episode to learn how banks became an intimate part of everyday life. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In today's world, it is almost impossible to go through the day without interacting with a bank—whether through a salary payment, a debit card, a credit card, or a digital ID used to access public services online. Yet this intimate relationship between households and banks is relatively recent. In this episode of the New Books Network, I speak with Orsi Husz, Professor at Uppsala University, about her book Bankminded: Banks as Intimate Agents of Everyday Life in Welfare State Sweden. The book traces how, from the late 1950s onwards, banks gradually became embedded in the everyday routines of ordinary people. Through wage accounts, credit cards, financial advice, and identity documents, financial institutions reshaped how households handled money—and how they thought about finance itself. Drawing on rich archival research, Husz shows that this transformation was not simply a story of technology or markets. It involved cultural shifts around class, gender, morality, and identity, as well as the surprising role of the welfare state in expanding everyday banking. The result was what she calls the “bankification” of everyday life—a process that laid the groundwork for the financialised world we inhabit today. If you are interested in the history of banking, the culture of finance, or how modern financial habits emerged, this conversation offers a fascinating perspective on a transformation that most of us now take for granted. You can download the book for free (Open Access) here Listen to the episode to learn how banks became an intimate part of everyday life. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/sociology

In today's world, it is almost impossible to go through the day without interacting with a bank—whether through a salary payment, a debit card, a credit card, or a digital ID used to access public services online. Yet this intimate relationship between households and banks is relatively recent. In this episode of the New Books Network, I speak with Orsi Husz, Professor at Uppsala University, about her book Bankminded: Banks as Intimate Agents of Everyday Life in Welfare State Sweden. The book traces how, from the late 1950s onwards, banks gradually became embedded in the everyday routines of ordinary people. Through wage accounts, credit cards, financial advice, and identity documents, financial institutions reshaped how households handled money—and how they thought about finance itself. Drawing on rich archival research, Husz shows that this transformation was not simply a story of technology or markets. It involved cultural shifts around class, gender, morality, and identity, as well as the surprising role of the welfare state in expanding everyday banking. The result was what she calls the “bankification” of everyday life—a process that laid the groundwork for the financialised world we inhabit today. If you are interested in the history of banking, the culture of finance, or how modern financial habits emerged, this conversation offers a fascinating perspective on a transformation that most of us now take for granted. You can download the book for free (Open Access) here Listen to the episode to learn how banks became an intimate part of everyday life. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/european-studies

In today's world, it is almost impossible to go through the day without interacting with a bank—whether through a salary payment, a debit card, a credit card, or a digital ID used to access public services online. Yet this intimate relationship between households and banks is relatively recent. In this episode of the New Books Network, I speak with Orsi Husz, Professor at Uppsala University, about her book Bankminded: Banks as Intimate Agents of Everyday Life in Welfare State Sweden. The book traces how, from the late 1950s onwards, banks gradually became embedded in the everyday routines of ordinary people. Through wage accounts, credit cards, financial advice, and identity documents, financial institutions reshaped how households handled money—and how they thought about finance itself. Drawing on rich archival research, Husz shows that this transformation was not simply a story of technology or markets. It involved cultural shifts around class, gender, morality, and identity, as well as the surprising role of the welfare state in expanding everyday banking. The result was what she calls the “bankification” of everyday life—a process that laid the groundwork for the financialised world we inhabit today. If you are interested in the history of banking, the culture of finance, or how modern financial habits emerged, this conversation offers a fascinating perspective on a transformation that most of us now take for granted. You can download the book for free (Open Access) here Listen to the episode to learn how banks became an intimate part of everyday life. Learn more about your ad choices. Visit megaphone.fm/adchoices

In today's world, it is almost impossible to go through the day without interacting with a bank—whether through a salary payment, a debit card, a credit card, or a digital ID used to access public services online. Yet this intimate relationship between households and banks is relatively recent. In this episode of the New Books Network, I speak with Orsi Husz, Professor at Uppsala University, about her book Bankminded: Banks as Intimate Agents of Everyday Life in Welfare State Sweden. The book traces how, from the late 1950s onwards, banks gradually became embedded in the everyday routines of ordinary people. Through wage accounts, credit cards, financial advice, and identity documents, financial institutions reshaped how households handled money—and how they thought about finance itself. Drawing on rich archival research, Husz shows that this transformation was not simply a story of technology or markets. It involved cultural shifts around class, gender, morality, and identity, as well as the surprising role of the welfare state in expanding everyday banking. The result was what she calls the “bankification” of everyday life—a process that laid the groundwork for the financialised world we inhabit today. If you are interested in the history of banking, the culture of finance, or how modern financial habits emerged, this conversation offers a fascinating perspective on a transformation that most of us now take for granted. You can download the book for free (Open Access) here Listen to the episode to learn how banks became an intimate part of everyday life. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/finance

Mindfulness enjoys a lot of popularity these days. In this episode, we talk to Professor Karen Brounéus (Uppsala University) about how we can integrate mindfulness exercises into our classrooms and how mindfulness can assist student learning. Not only has Karen been using mindfulness in her own peace and conflict studies courses, but she also offers mindfulness training to Swedish members of parliament. Karen shows how a lay person can make of these techniques and even offers an example of how this can be done. 

Here’s a podcast subject I bet you’ve never thought about. It did briefly occur to me as I continue to get birthday reminders from Facebook about friends I know who have died.  What happens to your digital life when you pass away?  Unlike previous technologies to preserve the dead–cemeteries, archives, photo albums, home movies–the internet is no longer something you visit and leave.  Many people will leave behind a daily account of who they were and what they were thinking. The vast necropolis is being built daily and the number of dead, say Facebook, accounts will over the next several decades outnumber social media accounts of the living.  This fact poses previously unconsidered concerns: who owns this material? what policies dictate its use and maintenance? will an ad-sponsored service have as an interest in maintaining those accounts when they are the digital record of people who no longer can buy products?  In 2019, then Twitter announced it would purge those accounts that had been inactive for more than six months.  What followed was an outcry by grieving relatives and friends and the company rescinded the policy.  Our guest, Carl Ohman, a digital ethicist at Uppsala University and the author of “The Afterlife of Data: What Happens to Your Information When You Die and Why You Should Care” joins us for a fascinating topic which goes beyond most checklists people have set up in preparation for death.

This week on the podcast we're time travelling with the fabulous Professor Keri Facer. How we think about the future or futures makes a difference to the decisions we make in schools today, and Keri has been asking critically important questions about educational futures, pasts and presents for the last 20 years, that are still as important today as they were when she published her brilliant 2011 book ‘Learning Futures: Education, Technology and Social Change'.Prof. Keri Facer is Professor of Educational and Social Futures at the University of Bristol, UK where she leads the British Academy ‘Times of a Just Transition' Programme, which brings together scholars from 6 continents and 14 disciplines, to explore how temporal assumptions, frames and processes structure the possibility of just transitions. She is also Co-investigator on the ESRC Centre for Sociodigital Futures, where she works on the implications of mixed reality tools for collective imagination. Keri is also Professor of Public Education at Black Mountains College, led by recent podcast guest, Ben Rawlence: https://www.goodimpactlabs.com/podcast/ben-rawlence.Keri was previously Zennström Professor in Climate Change Leadership at Uppsala University, expert advisory group member of UNESCO's Futures of Education Commission and Research Director at Futurelab. Keri is collaborating with the poverty charity, the Joseph Rowntree foundation, on their ‘imagination infrastructure' programme and is Editor-in-Chief of the journal Futures. Keri is also a co-Investigator of Transforming Education for Sustainable Futures: https://tesf.network/ In 2026, she is consolidating this work in three landmark publications: Chronoberg: a handbook of creative methods for temporal imagination (with Johannes Stripple); ‘Time & Possibility: A Field Guide' (with Harriet Hand); and Temporal Justice, a Special Issue for the Journal of Global Social Challenges. Keri's books include ‘Learning Futures: Education, Technology and Social Change' and ‘Working with Time in Qualitative Research'. She is joint Editor-in-Chief of the Journal ‘Futures' and she edits the Routledge Book Series on ‘Futures and Anticipation' with Prof Johan Siebers.Keri's personal website: https://kerifacer.wordpress.com/ https://www.linkedin.com/in/keri-facer-2a11b62/https://www.temporalimagination.org/https://www.conversationsociety.org/home https://www.jrf.org.uk/imagination-infrastructures/educating-the-ecological-imagination-the-work-of-black-mountainshttps://www.routledge.com/Learning-Futures-Education-Technology-and-Social-Change/Facer/p/book/9780415581431

In this podcast episode, MRS Bulletin's Laura Leay interviews Kunli Xiong from Uppsala University in Sweden about his development of metapixels as small as 560 nm, conducive for small video displays that can be located close to the human eye. Instead of using emissive pixels, Xiong uses electronic paper made up of tungsten trioxide nanodisks. By tuning the diameter and spacing of the nanodisks, certain wavelengths of light can be selectively reflected, leading to a color display. The degree of light reflection can be modulated by making use of the material's electrochromic properties. This work was published in a recent issue of Nature. 

Are you ready for an uncomfortable question… What happens to your data after you die?Buckle up — in this episode, Matthew Roberts is joined by Carl Öhman, Associate Professor at Uppsala University and author of The Afterlife of Data, to explore what becomes of our personal information after death and the ethical, political, and cultural consequences of our digital legacies.Tune in as Matt seeks Carl's perspective on what happens when today's tech giants gain access to the data of millions of deceased users. Together, they dive into how “death data” might be regulated, monetized, and ultimately controlled. From advertising and memorialized profiles to data ownership and the recording of history, this episode opens Pandora's box at the intersection of morality, business, and memory.This episode may not have all the answers, but it undeniably has all the questions you should be asking.

In this episode, we sit down with archaeologist Cecilia Ljung from Uppsala University to explore one of the biggest transformations of the Viking Age: the shift from Norse pagan traditions to Christianity.Through graves, runestones, and early towns, we follow the physical evidence of how belief, ritual, and daily life changed across Scandinavia.Subscribe to stay updated! Also available on all platforms where podcasts are found, such as Spotify, Apple Podcasts, Amazon Music and more. Find all the links in our linktree: https://linktr.ee/grimfrost

Dominic is joined by the inimitable Prof. Emma Clery - author of The Rise of Supernatural Fiction 1762-1800 and Professor of English Literature at Uppsala University, Sweden. They continue this month's theme of the supernatural, taking you on a journey into the heart of an event that caused a sensation in Georgian London, and would inspire Dickens decades later …The real life story of The Cock Lane Ghost set the stage for an earnest debate between Anglicans and Methodists - the former skeptical the latter credulous towards a spirit realm - where the dead can seek out the living and communicate with them. The alleged haunting in Cock Lane quickly spiralled in the first months of 1762, with many great figures of the age Samuel Johnson, Horace Walpole and Prince Edward, Duke of York attending seances to cross examine the ghost. At the heart of the controversy lay the very serious charge of murder that the ghost - known as ‘Scratching Fanny' - was trying to convince her hearers of, and the very real possibility of the man accused being sent to the gallows.It will come as no surprise to you that Dickens loved this story! Mentioning it not only in articles but in three of his novels - through Mrs Nickleby's flighty imagination, the disgruntled temper of Mrs Pipchin, and as Prologue to the madness and terror that engulfs A Tale of Two Cities …Joining us to bring to life the real characters from this story - in the form of articles, letters and transcripts - are the fantastic actors Peter Bray and Rachel Winters.Additional Sound Effects in this episode have been used under license from Epidemic Sounds Support the showIf you'd like to make a donation to support the costs of producing this series you can buy 'coffees' right here https://www.buymeacoffee.com/dominicgerrardThank you so much!Host: Dominic GerrardSeries Artwork: Léna GibertOriginal Music: Dominic GerrardThank you for listening!

A New England Journal of Medicine study showed a novel chemotherapy regimen, trastuzumab deruxtecan combined with pertuzumab, outperformed the current standard in treating HER2-positive advanced breast cancer, demonstrating better efficacy and tolerability with fewer traditional chemotherapy-related side effects. A JAMA Oncology study by Uppsala University revealed a modest increase in breast cancer risk with hormonal contraceptive use among over two million Swedish women, emphasizing the need for balanced counseling regarding risks and benefits. The REPAIR trial in Denmark, published in the British Medical Journal, demonstrated that a short course of antibiotics significantly reduced clinically important wound complications after vaginal delivery in women with episiotomies or second-degree tears, highlighting its potential benefit in postpartum care.

In this episode, Martha Middlemiss Lé Mon joins Maurice for a deep and thoughtful conversation about the intersections of faith, education, and human flourishing. Martha, a researcher and educator at Uppsala University's Faculty of Theology, reflects on her work exploring how religious and worldview education can foster understanding, empathy, and coexistence in plural societies.   Together, they discuss what it means to teach and learn across difference, how faith-based perspectives can enrich moral and civic education, and why spaces for open dialogue matter more than ever in today's polarized world. The conversation weaves through themes of values, belonging, and inner development — inviting listeners to think about how education and faith together can shape more compassionate communities.   Martha leads research at the Uppsala Religion and Society Research Centre and is deeply engaged in international collaborations on religious literacy, worldview education, and intercultural understanding. Her work bridges academia, policy, and practice to promote peace, equality, and meaningful dialogue.   Listener Engagement: Learn more about Martha's work via her Uppsala University profile. Connect with her on LinkedIn. Share your feedback on this episode through our Walk Talk Listen Feedback link – your thoughts matter! Follow Us: Support the Walk Talk Listen podcast by following us on Facebook and Instagram. Visit 100mile.org or mauricebloem.com for more episodes and information about our work. Check out the special series "Enough for All" and learn more about the work of the Joint Learning Initiative (JLI).

When we think about flashpoints between India and Pakistan, most people picture borders, bombs, or Kashmir. But the most strategic weapon in South Asia today may not be nuclear—it's water.The Indus Water Treaty has been called one of the world's most successful peace agreements, surviving wars, nuclear standoffs, and decades of political hostility. But in April this year, India suspended the treaty after a terrorist attack in Kashmir, effectively threatening to choke off the lifeline of Pakistan's agriculture and economy. For the first time in 65 years, the Indus—an ancient river system that sustains over 250 million people—has been turned into a tool of coercion.This is more than a regional spat. It's a live experiment in how climate stress, nationalism, and security fears can dismantle one of the last bastions of cooperation between nuclear rivals. And if water becomes a weapon here, what does it mean for other fragile river basins—the Nile, the Mekong, the Jordan—where upstream states already hold the cards?Today, I'm joined by Professor Ashok Swain, UNESCO Chair on International Water Cooperation and Head of Peace and Conflict Research at Uppsala University. He has authored and edited 20 books and more than 150 journal articles, and he is also the Founding Editor-in-Chief of the peer-reviewed journal Environment and Security, published by Sage. He has also served as a consultant on environmental and development issues, advising various international organisations, including UN agencies, OCSE, NATO, EU, IISS, the Arab League and Oxfam, as well as the governments of Sweden, the Netherlands, the United Kingdom and Singapore. Few people understand more about how rivers can both unite and divide nations. His work spans transboundary water politics, climate security, and conflict dynamics, and he has been one of the most vocal critics of India's suspension of the Indus Water Treaty.The International Risk Podcast brings you conversations with global experts, frontline practitioners, and senior decision-makers who are shaping how we understand and respond to international risk. From geopolitical volatility and organised crime, to cybersecurity threats and hybrid warfare, each episode explores the forces transforming our world and what smart leaders must do to navigate them. Whether you're a board member, policymaker, or risk professional, The International Risk Podcast delivers actionable insights, sharp analysis, and real-world stories that matter.Dominic Bowen is the host of The International Risk Podcast and Europe's leading expert on international risk and crisis management. As Head of Strategic Advisory and Partner at one of Europe's leading risk management consulting firms, Dominic advises CEOs, boards, and senior executives across the continent on how to prepare for uncertainty and act with intent. He has spent decades working in war zones, advising multinational companies, and supporting Europe's business leaders. Dominic is the go-to business advisor for leaders navigating risk, crisis, and strategy; trusted for his clarity, calmness under pressure, and ability to turn volatility into competitive advantage. Dominic equips today's business leaders with the insight and confidence to lead through disruption and deliver sustained strategic advantage.Tell us what you liked!

Thank you Bruce Lanphear, Clyde Wilson, Tracy Dennis-Tiwary, Diego Pereyra, Dr Mike Hunter, and many others for tuning into my live video with Charlotte Blease! Join me for my next live video in the app.Whether A.I. will transform the practice of medicine in a positive way remains controversial. Health researcher Prof Charlotte Blease, on faculty at Uppsala University in Sweden and researcher at Harvard University, has written a new book —Dr. Bot—that critically assesses the unmet needs in healthcare and whether A.I. can fulfill them. She provides an optimistic viewpoint (see the subtitle), and our conversation probes whether that is justified. She has a substack, too, hereThanks for listening to Ground Truths. Through analytic essays and podcasts, I try to cover the important issues and discoveries in life science and medicine. If you have suggestions for topics I should get into, please pass them along. Get full access to Ground Truths at erictopol.substack.com/subscribe

******Support the channel******Patreon: https://www.patreon.com/thedissenterPayPal: paypal.me/thedissenterPayPal Subscription 1 Dollar: https://tinyurl.com/yb3acuuyPayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9lPayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpzPayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9mPayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao ******Follow me on******Website: https://www.thedissenter.net/The Dissenter Goodreads list: https://shorturl.at/7BMoBFacebook: https://www.facebook.com/thedissenteryt/Twitter: https://x.com/TheDissenterYT This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/ Dr. Charlotte Blease is an interdisciplinary health researcher at the Department of Women's and Children's Health at Uppsala University, Sweden, and the Digital Psychiatry Division at the Beth Israel Deaconess Medical Center at the Harvard Medical School. She is a former Fulbright Scholar and a winner in 2012 of the UK-wide BBC Radio 3's New Generation Thinkers Competition. Dr. Blease has written extensively about the ethics of placebo and nocebo effects. Her research has been profiled by international news outlets including The Washington Post, The Guardian, and The Sydney Morning Herald. Her latest book is Dr. Bot: Why Doctors Can Fail Us―and How AI Could Save Lives. In this episode, we focus on Dr. Bot. We start by talking about medical error, whether doctors are essential, barriers in accessing medicine, and symptom denial. We discuss which are the better interviewers: doctors or computers. We talk about the limitations of doctors in diagnostics and treatment, and whether AI can do better. We discuss whether AI can be biased. Finally, we talk about the role that AI can play in medicine.--A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: PER HELGE LARSEN, JERRY MULLER, BERNARDO SEIXAS, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, ROBERT WINDHAGER, RUI INACIO, ZOOP, MARCO NEVES, COLIN HOLBROOK, PHIL KAVANAGH, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, FERGAL CUSSEN, HAL HERZOG, NUNO MACHADO, JONATHAN LEIBRANT, JOÃO LINHARES, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, ROMAIN ROCH, DIEGO LONDOÑO CORREA, YANICK PUNTER, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, NELLEKE BAK, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, HEDIN BRØNNER, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, SCOTT, ZACHARY FISH, TIM DUFFY, SUNNY SMITH, JON WISMAN, WILLIAM BUCKNER, LUKE GLOWACKI, GEORGIOS THEOPHANOUS, CHRIS WILLIAMSON, PETER WOLOSZYN, DAVID WILLIAMS, DIOGO COSTA, ALEX CHAU, CORALIE CHEVALLIER, BANGALORE ATHEISTS, LARRY D. LEE JR., OLD HERRINGBONE, MICHAEL BAILEY, DAN SPERBER, ROBERT GRESSIS, JEFF MCMAHAN, JAKE ZUEHL, BARNABAS RADICS, MARK CAMPBELL, TOMAS DAUBNER, LUKE NISSEN, KIMBERLY JOHNSON, JESSICA NOWICKI, LINDA BRANDIN, VALENTIN STEINMANN, ALEXANDER HUBBARD, BR, JONAS HERTNER, URSULA GOODENOUGH, DAVID PINSOF, SEAN NELSON, MIKE LAVIGNE, JOS KNECHT, LUCY, MANVIR SINGH, PETRA WEIMANN, CAROLA FEEST, MAURO JÚNIOR, 航 豊川, TONY BARRETT, NIKOLAI VISHNEVSKY, STEVEN GANGESTAD, TED FARRIS, HUGO B., JAMES, JORDAN MANSFIELD, CHARLOTTE ALLEN, PETER STOYKO, DAVID TONNER, LEE BECK, PATRICK DALTON-HOLMES, NICK KRASNEY, RACHEL ZAK, AND DENNIS XAVIER!A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, TOM VANEGDOM, BERNARD HUGUENEY, CURTIS DIXON, BENEDIKT MUELLER, THOMAS TRUMBLE, KATHRINE AND PATRICK TOBIN, JONCARLO MONTENEGRO, NICK GOLDEN, CHRISTINE GLASS, IGOR NIKIFOROVSKI, PER KRAULIS, AND JOSHUA WOOD!AND TO MY EXECUTIVE PRODUCERS, MATTHEW LAVENDER, SERGIU CODREANU, ROSEY, AND GREGORY HASTINGS!

How can AI improve our healthcare industry? In this episode, Dr Emma Yhnell speaks to health informaticist and author Dr Charlotte Blease about the role AI could play in the future of medicine, from making it more accessible to helping lighten the hours of a burnt-out workforce.  Healthcare systems around the world are under mounting pressure. Healthcare professionals are amongst the most overworked, with half of all US doctors being burnt out and 42% of UK  doctors feeling unable to cope with their weekly workload. Studies show that burnout is linked to increased rates of error and harm, which in the medical industry could mean the difference between catching a diagnosis in time or risking a patient's life. But Dr Charlotte Blease argues that this need not be the case. It is time to thoughtfully implement the new technologies of our age to revolutionize the healthcare industry. AI can help us to overhaul a system that is reaching capacity and has the potential to change lives, both for doctors and their patients.  Dr Charlotte Blease is a health informaticist with a background in philosophy. She has published more than 150 peer-reviewed journals and books on healthcare and is an Associate Professor at the Participatory eHealth and Health Data Research Group at Uppsala University and Researcher at Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School. Her latest book is Dr Bot: Why Doctors Can Fail and How AI Could Save Lives. If you'd like to become a Member and get access to all our full conversations, plus all of our Members-only content, just visit intelligencesquared.com/membership to find out more. For £4.99 per month you'll also receive: - Full-length and ad-free Intelligence Squared episodes, wherever you get your podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series - 15% discount on livestreams and in-person tickets for all Intelligence Squared events  ...  Or Subscribe on Apple for £4.99: - Full-length and ad-free Intelligence Squared podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series … Already a subscriber? Thank you for supporting our mission to foster honest debate and compelling conversations! Visit intelligencesquared.com to explore all your benefits including ad-free podcasts, exclusive bonus content and early access. … Subscribe to our newsletter here to hear about our latest events, discounts and much more. https://www.intelligencesquared.com/newsletter-signup/ Learn more about your ad choices. Visit podcastchoices.com/adchoices Learn more about your ad choices. Visit podcastchoices.com/adchoices

Milk: drink a lot of it and we'll grow big and tall with strong bones. That's what many people are told as children, but just how true is this accepted wisdom? CrowdScience listener JJ in Singapore is sceptical. He wants to live a healthy life for as long as possible, and he's wondering whether drinking cow's milk will help or hinder him on this mission. All mammals produce milk, and our mother's milk is our very first drink as babies. So what actually is the white stuff? Mary Fewtrell, professor of paediatric nutrition at UCL, gives presenter Chhavi Sachdev the lowdown on just how fundamental breastmilk is to us all. But are we meant to continue drinking milk from other animals once we grow up? This behaviour of ours is rare among mammals… so Christina Warinner, professor of evolutionary biology at Harvard University, tells us when in our history cow's milk entered our diet, and how we even came to be able to digest it. And is there any truth in the accepted wisdom that cow's milk will give us stronger bones? Karl Michaelsson, professor of medical epidemiology at Uppsala University, has researched just this – and the answer isn't what you'd expect. Karl helps Chhavi sift through the complex evidence to see whether milk is actually any good for us.Presenter: Chhavi Sachdev Producer: Sophie Ormiston Editor: Ben Motley(Photo:Lady milking cow, Nadiad, Gujarat, India)

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A 42-year-old man who has lived most of his life with type 1 diabetes has become the first human to receive a transplant of genetically modified insulin-producing cells. This marks the first pancreatic cell transplant in a human to sidestep the need for immunosuppressant drugs. “This is the most exciting moment of my scientific career,” says cell biologist Per-Ola Carlsson of Uppsala University in Sweden, who helped develop the procedure. The new treatment, he says, “opens the future possibility of treating not only diabetes but other autoimmune diseases.” This procedure uses the gene editing technique, CRISPR, to discourage the auto immune attack on the donor cells. Before the transplant, the participant had no measurable naturally produced insulin and was receiving daily doses of the hormone. But within four to 12 weeks following the transplant, his levels rose slightly on their own after meals—showing that the new beta cells were releasing some insulin in response to glucose. even though the new study is promising, it involved just one participant and is therefore preliminary. And longer-term monitoring is needed to confirm the therapy's safety before it can be offered to more people. She also notes that the injected cells produced only 7 percent of the insulin needed for a person to be fully independent of additional medication. The researchers supplied the recipient with insulin doses to maintain healthy blood sugar levels. While Herold thinks it's still too early to consider this approach for a cure, “these options are now here to change the disease in ways that have never been possible before,” he says. “There's tremendous hope.” https://www.scientificamerican.com/article/type-1-diabetes-patients-insulin-production-restored-with-new-cell/ XX   This one is interesting… a recent study shows that children of mothers with gestational diabetes or fathers with type 2 diabetes have higher chances of developing type 1 diabetes than kids whose parents do not have any type of diabetes. Specifically, the study found that children whose mothers had gestational diabetes during pregnancy were 94% more likely to develop type 1 diabetes compared to children of mothers without diabetes. Similarly, having a father with type 2 diabetes was linked to a 77% higher risk. The study also suggests a possible link between maternal type 2 diabetes and type 1 diabetes in children, although more data are needed to confirm whether the risk is real.   "What is interesting is that type 1 diabetes is a disease of lack of the hormone insulin while gestational diabetes and type 2 diabetes stem mostly from the body's resistance to the hormone. What may be happening is that genes, environments and behaviors that create insulin resistance may also, in some cases, trigger the immune reactions that lead to type 1 diabetes," adds Dr. Dasgupta. A 2019 meta-analysis by researchers at Soochow University in China found that gestational diabetes was linked to a 66% higher risk of type 1 diabetes in children. This new study, which includes more than twice as many studies, offers a robust synthesis of current evidence and shows the risk is even greater than previously estimated. It is also the first meta-analysis to examine the link between paternal type 2 diabetes and type 1 diabetes in offspring. "Several mechanisms may be at play. Families often share lifestyle and eating habits, which can raise the likelihood that children will be affected. But beyond that, high blood sugar levels may also cause biological changes in parents that could increase their children's risk of developing type 1 diabetes," explains Laura Rendon, co-first author of the study, who completed an MSc in experimental medicine at The Institute and, as someone living with type 1 diabetes herself, finds deep personal meaning in conducting this research. For instance, the authors suggest that high blood sugar during pregnancy may stress the fetus's insulin-producing beta cells, reducing their number at birth or making them more vulnerable to damage later in life. It may also trigger epigenetic changes—modifications to proteins and molecules attached to DNA—that increase the risk. Likewise, high blood sugar in fathers with type 2 diabetes may cause epigenetic changes in their sperm, potentially influencing their child's risk of developing type 1 diabetes. https://medicalxpress.com/news/2025-08-diabetes-children-linked-parents.html XX Can a CGM help you lose weight? The company Signos is banking on it – the just got FDA approval for their system, which uses the over the counter Dexcom Stelo. The claim here is that the system will help track how food choices, activity, stress and sleep can all affect metabolism. Signos also works in partnership with the digital nutrition counseling startup Nourish. It currently offers a quarterly subscription plan, including six CGM sensors, for $139 per month. And they tell you don't take any medical actions based on the app's output without consulting a physician. https://www.fiercebiotech.com/medtech/fda-clears-signos-over-counter-cgm-powered-weight-loss-app XX Good news for T1D1, a free mobile app that helps people calculate insulin doses, track daily data, and share insights with healthcare providers. After being pulled off the market with similar apps a few years ago, it's now back and FDA approved. Drew Mendelow created the app after his diagnosis at age 13. He came on the show last year and I'll link his story up in the show notes. Diabetes Center Berne provided the initial funding to support the T1D1 efforts to redesign the app per FDA standards.  Comerge AG , the registered manufacturer, enlisted a team of software engineers, regulatory experts, and design professionals to ensure T1D1 was FDA-ready. Dexcom graciously conducted the Human Factors study to ensure safety and accuracy.  ​ ​T1D1 is now FDA-cleared as a Class II medical device and is the first over-the-counter insulin calculator cleared for individuals aged 2 and older. T1D1 is expected to be live in the AppStore and Google Play Store by October 2025. https://diabetes-connections.com/the-fda-took-down-this-teens-free-bolus-calculator-he-needs-your-help-to-bring-it-back/ XX Metformin has been the standard treatment for type 2 diabetes for more than six decades, yet scientists still do not fully understand how it works. A team from Baylor College of Medicine, working with international collaborators, has now identified an unexpected factor in its effectiveness: the brain. Their findings reveal a brain pathway involved in metformin's glucose-lowering action, pointing to new strategies for treating diabetes with greater precision. The study was published in Science Advances. The researchers concentrated on a small protein called Rap1, located in a region of the brain known as the ventromedial hypothalamus (VMH). They discovered that metformin's ability to lower blood sugar at clinically relevant doses depends on suppressing Rap1 activity in this brain area.   “This discovery changes how we think about metformin,” Fukuda said. “It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”     https://scitechdaily.com/after-60-years-scientists-uncover-hidden-brain-pathway-behind-diabetes-drug-metformin/   XX Looks like GLP-1 pills are moving ahead. Lilly says it's version helped overweight adults with type 2 lose 10% of their body weights and lower A1C. Just two weeks ago, we were talking about how the same drug in people without diabetes had less than the stellar expected results. Orforglipron is a small-molecule pill that is easier to manufacture and package than wildly popular injectable drugs for obesity, such as Lilly's Zepbound and Novo Nordisk's NOVOb.CO rival treatment Wegovy, which are peptide mimics of the appetite-controlling GLP-1 hormone. In the 72-week study of more than 1,600 overweight or obese adults with type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds (10.43 kg), versus 2.2% for those who received a placebo, achieving the main goal of the trial. Patients on the lowest 6 mg dose of the Lilly drug lost 5.5% of their weight. https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/ XX     An intervention that combined a low-calorie Mediterranean diet and exercise led to less diabetes incidence in older adults. Men had a greater diabetes risk reduction with the intervention than women. The study was based in Spain, and the diet may not be as easy to adhere to in the U.S. Among nearly 5,000 adults with metabolic syndrome and overweight or obesity in the PREDIMED-Plus trial, those who followed this intervention had a 31% lower risk for type 2 diabetes over 6 years relative to those who received only ad libitum Mediterranean diet advice (aHR 0.69, 95% CI 0.59-0.82). the Mediterranean diet focuses on high intake of plant-based foods, moderate consumption of fish, poultry, and dairy with optional red wine, and low intake of red meats, sweets, and sugar-sweetened beverages. Common foods featured in the diet include extra-virgin olive oil, fruits, vegetables, legumes, nuts, and whole grains. However, Sharon Herring, MD, MPH, and Gina Tripicchio, PhD, MSEd, both of Temple University in Philadelphia, pointed out that this study was conducted solely in Spain, and sticking to this type of diet may be more challenging in countries like the U.S.   "Participants in the study received extra-virgin olive oil to support adherence and retention; in the United States, prices of extra-virgin olive oil have nearly doubled since 2021 due to a combination of factors including climate change, rising production costs, supply chain disruptions, and now tariffs," they noted in an accompanying editorial. "[T]he large number of dietitian contacts during the study may prove difficult to scale broadly in the United States given challenges with health care access and reimbursement for prevention services."         https://www.medpagetoday.com/primarycare/diabetes/117151 XX A group of Canadian researchers has identified an unexpected way to lower blood sugar and protect the liver: by capturing a little-known fuel produced by gut bacteria before it enters the body and causes harm. The findings, published in Cell Metabolism, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Scientists from McMaster University, Université Laval, and the University of Ottawa discovered that a molecule generated by gut microbes can cross into the bloodstream, where it drives the liver to overproduce glucose and fat. By designing a method to trap this molecule in the gut before it reaches circulation, they achieved striking improvements in blood sugar regulation and fatty liver disease in obese mice. https://scitechdaily.com/scientists-discover-a-surprising-new-way-to-fight-diabetes/ XX Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego, according to the San Diego Union Tribune. The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing. The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google's corporate parent. Verily's work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.” A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.” https://timesofsandiego.com/business/2025/08/27/report-life-sciences-firm-dexcom-lay-off-200-san-diego-workers/ XX Front office changes at Insulet. Eric Benjamin, former chief product and customer experience officer, will take the role of chief operating officer, effective immediately. Manoj Raghunandanan Mu-NOHJ Rug-a-nun-da-nun to the position of chief growth officer, leading Insulet's new growth organization. The appointments are some of CEO Ashley McEvoy's first changes since she was hired in April. The appointments come after McEvoy outlined four priorities for Insulet on an August earnings call:   enhancing the company's commercial capabilities, building Insulet's brand and direct-to-consumer capabilities, driving growth outside of the U.S. and accelerating the pace of innovation. https://www.medtechdive.com/news/insulet-eric-benjamin-manoj-raghunandanan-appointments/758668/ XX   XX Want to highlight The Children's Diabetes Foundation in Colorado – they held a medal ceremony for patients of the Barbara Davis Center who've lived with Type 1 diabetes for 50 years or more. There were 87 medal recipients in the ceremony including Dana Davis, Executive Director of the Children's Diabetes Foundation and the daughter of the founders of the Barbara Davis Center. Davis shared: "When you got Type1 diabetes in the 70s, they thought you shouldn't have children. They thought you weren't going to live past 30 or 40. It was definitely very different," Davis said.   https://www.cbsnews.com/colorado/news/barbara-davis-center-celebrates-colorado-type-1-diabetes-patients-milestone/

Today on Sauna Talk, we welcome a very special guest. Dr. Hans Hägglund. Who is Dr. Hans Hägglund? Hans Hägglund MD, PhD, is a medical doctor and professor at Uppsala University, in Northern Sweden. Professor Hägglund has a strong research back ground in clinical research within medicine. He graduated from Karolinska institute, Sweden and did his post doc at Fred Hutchinson Cancer Research Center in Seattle, USA. Between 2013 and 2018 he served as the director of the Cancer Center at Uppsala University Hospital. Professor Hägglund also had the position as the national cancer coordinator at The Swedish Association of Local Authorities and Regions (SALAR) between 2019-2022. He currently holds a position as a senior consultant at Karolinska University Hospital in Stockholm, which is where we catch up with him for this episode of Sauna Talk. Hot facts On this episode of Sauna Talk, we recognize that Hans Hägglund is a man who wears many hats in the world of health, wellness, and sauna culture. Hans is an affiliated researcher at the Center for Resilient Health at the Stockholm School of Economics, and co-founder of Vision Zero Cancer in Sweden. Known by many as the “sauna doctor,” he serves at the Swedish Sauna Academy, sits on the board of the Sauna Research Institute and the International Sauna Association, and played a key role in organizing the XVII International Sauna Congress in Haparanda/Tornio back in 2018. His book The Sauna Book – Hot Facts on Sauna and Health, published in Swedish in 2020, has attracted wide attention for the way it bridges science and tradition. We explore why sauna and cold bathing are seeing a surge in global interest, and what challenges remain in researching their health benefits. Hans shares his thoughts on why sauna bathing should be considered alongside traditional medicine, gives us a glimpse into the new book he's writing, and reflects on how prevention can be far more cost-effective than treatment. Along the way, we discuss his professional journey, the boards he serves on, and even his earliest sauna memories. And, of course, we'll hear his take on one of my favorite questions: from a Swedish — and global — perspective, what's the most misunderstood thing about sauna that he wishes more people knew? Let's welcome Dr. Hans Hägglund to Sauna Talk. Here's a short intro for social medializing: “In this episode of Sauna Talk, I sit down with Hans Hägglund — “the sauna doctor” — affiliated researcher, co-founder of Vision Zero Cancer, and board member of the International Sauna Association. We dive into the rising global interest in sauna and cold bathing, the challenges of sauna research, and why prevention may be the most powerful medicine. Hans also shares personal sauna memories, his upcoming book project, and what he believes is the most misunderstood thing about sauna.” Punchy one sentences: From Swedish sauna congresses to cold plunges, Hans Hägglund brings the heat — and the science — to Sauna Talk. What's the most misunderstood thing about sauna? “The sauna doctor” Hans Hägglund has a prescription. Sauna, science, and a splash of cold water — Hans Hägglund joins Sauna Talk for a deep dive into the health of heat.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

  On this episode of Unsupervised Learning Razib talks to human geneticist Cesar Fortes-Lima about his paper from earlier this year, Population history and admixture of the Fulani people from the Sahel. Fortes-Lima has a Ph.D. in Biological Anthropology, and his primary research areas include African genetic diversity, the African diaspora, the transatlantic slave trade, demographic inference, admixture dynamics and mass migrations. Formerly a postdoctoral fellow in the Department of Human Evolution at Uppsala University, Forest-Lima is now an instructor in genetic medicine at the Johns Hopkins University. He is also a returning guest to the podcast, having earlier come on to discuss his paper The genetic legacy of the expansion of Bantu-speaking peoples in Africa. Razib and Fortes-Lima first contextualize who the Fulani are in the West African socio-historical context, in particular, their role as transmitters of Islam across the Sahel. They also discuss the importance of having numerous Fulani subpopulations in the publication; earlier work had generalized about the Fulani from a small number of samples from a single tribe. Fortes-Lima highlights the primary finding, in particular, that the Fulani seem to have what we now call “Ancient North African” (ANA) ancestry. That people was related to, but not descended from, the “out of Africa” population which gave rise to Eurasians. They also explore the role of natural selection in allowing the Fulani to subsist on a diet high in milk, and how the Fulani lactase persistence mutation is exact same with Eurasians rather than East Africans. Fortest-Lima also reviews some of the earlier 20th-century anthropological speculations about the origins of the Fulani, and what his results show about their affinities (or lack thereof) to groups in West Asia and the Maghreb.

Breaking climate news: hot humid heat domes over Eastern North America, UK, and Europe. Scientist Michael Mann blames changed planetary waves. Gabriele Messori, Uppsala University: “whiplash” combined climate hazards increasing. Body's heat tolerance lower than we were told. Dr. Daniel Vecellio on “Greatly  …

As part of the US HUPO sponsored "Alt Proteomics" series highlighting alternative proteomics things, Ben and Ben sit down to talk with Dr. Cecilia Lindskog, Uppsala University.

JUST HOW UNEQUAL IS OUR WEALTH? If you listen to Bernie Sanders rich people are literally stealing the change from poor people's pockets, but of course that is false. But the Gospel of Wealth Inequality is a powerful elixir doled out to gin up envy and greed in the people and it's effective. But is it true? At 1 I'm talking with Daniel Waldenstrom, Professor of Economics, Research Institute of Industrial Economics, Stockholm, Sweden Previously professor at Paris School of Economics, Uppsala University, UCLA about his work on it, and it tells a much different story. Read this for more, but we will dig in today. Find his book on the subject, Richer and More Equal: A New History of Wealth in the West by clicking here.

Rune Hjarnø Rasmussen is a Historian of Religion, Ph.d from Uppsala University in Sweden. His research into Afro-diasporic strategies for maintaining animist reality in the modern world has lead him towards reading North European cultural history from the perspective of rejected animist knowledge and practice. The objective is to recover Euro-traditioanl forms of landconnectedness ecological knowledge and kinship with the greater community of beings. Rune has lived in a number of countries in Europe, Africa North- and South America and presently runs the platform “Nordic Animism”. Links: Nordic Animism YouTube Instagram Topics 00:00 Introduction and Guest Welcome00:49 Rune's Background and Nordic Animism03:13 Understanding Nordic Animism07:34 Decolonization and Animism11:45 Animism in Daily Life21:49 Relational Practices and Cultural Renewal37:10 Animism and Modern Challenges47:51 Resources and Upcoming Projects50:17 Conclusion and Farewell Join Rune for the free global premiere of The Eternal Song and a 7-day online gathering centered on Indigenous voices—part of the online SAND event, happening June 3–9. Support the mission of SAND and the production of this podcast by becoming a SAND Member

This week, we look beyond the physical infrastructure supporting our lives to the owners taking over that infrastructure: asset managers. Brett Christophers, an author, professor, and economic geographer at Uppsala University in Sweden, joins me to explore the troubling transformation of infrastructure ownership in today's economy. From housing to energy to water, massive asset management firms like Blackstone and Brookfield have positioned themselves more and more between citizens and essential services, extracting wealth while taking minimal risk. Christophers explains how this shift from public to private control has reshaped our relationship with everyday infrastructure, particularly as we attempt to transform our energy supplies. He argues that the profit-driven approach of these financial giants is at odds with the public good, creating a system where even as things like renewable technology get cheaper, their deployment slows due to insufficient returns for investors.

On 21st April 2025, Pope Francis, the head of the Catholic Church, died. His funeral took place on 26th April, with thousands of mourners crowding into St Peter's Square to pay their respects. Following the death of a Pope, there are centuries-old traditions and rituals that must be followed, and that got the Unexpected Elements team thinking about the science surrounding loss. First up, we delve into the thorny issue of when early humans started to carry out funerary rituals, before turning our attention to graveyards and the life that thrives within these sacred environments.   Next, we are joined Carl Öhman from Uppsala University in Sweden, who reveals what happens to our data when we die and why we should care about it. Plus, we discuss the precious materials hiding in our old devices, and find out whether animals mourn. All that, plus many more Unexpected Elements.    Presenter: Marnie Chesterton, with Andrada Fiscutean and Edd Gent   Producers: Margaret Sessa Hawkins, with Alice Lipscombe-Southwell, Robbie Wojciechowski and Minnie Harrop

Did you know that Ukraine is the fourth largest corn exporter globally? This is not the beginning of a Soviet joke. . . Ukraine plays a crucial role on the world food market. About sixty percent of its exports are agricultural products with destinations in Europe, Asia, and Africa. Ukraine also accounts for around one-sixth of the world wheat and barley markets and a staggering half of the world's supply of sunflower oil. But Ukrainian agribusiness is under stress. Soviet and post-Soviet legacies abound. Climate change and depleted soil pose long term obstacles. And Russia's invasion has only increased the calamity thanks to destruction, theft, and environmental damage. How do things look at the moment? In the fourth event in our Eurasian Environments series, the Eurasian Knot spoke to Susanne Wengle and Natalia Mamonova about Ukraine's past and present place in the global food system, the impact of the war, and the prospects of renewal and recovery. Guests:Susanne Wengle is professor of Russian and Eurasian studies at Uppsala University and associate professor of political science at the University of Notre Dame. Her most recent book is Black Earth, White Bread: A Technopolitical History of Russian Agriculture and Food published by the University of Wisconsin Press.Natalia Mamonova is a senior researcher at RURALIS - Institute for Rural and Regional Research, Norway. Her current research at RURALIS mainly focuses on the impact of the war in Ukraine on the Ukrainian and global food systems.Send us your sounds! PatreonKnotty News Hosted on Acast. See acast.com/privacy for more information.

These days, so much of our lives takes place online - but what about our afterlives? A recent study by the Oxford Internet Institute predicts that the number of deceased Facebook users could outnumber the living by 2070. As AI advances, a debate is growing over digital remains and what should be done with the vast amounts of data we leave behind. In this episode, Carl Öhman, author of The Afterlife of Data: What Happens to Your Information When You Die and Why You Should Care, explores the ethics, politics, and future of our digital identities. Named one of The Economist's Best Books of 2024, Öhman's work sheds light on who truly owns our data after death - and whether we should have a say in our digital legacy. Carl Öhman is an assistant professor of political science at Uppsala University, Sweden. His research spans several topics, including the politics and ethics of AI, deepfakes and digital remains. He is joined in conversation by Stephanie Hare, researcher, broadcaster, and author of Technology is Not Neutral: A Short Guide to Technology Ethics.  If you'd like to become a Member and get access to all our full conversations, plus all of our Members-only content, just visit intelligencesquared.com/membership to find out more. For £4.99 per month you'll also receive: - Full-length and ad-free Intelligence Squared episodes, wherever you get your podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series - 15% discount on livestreams and in-person tickets for all Intelligence Squared events  ...  Or Subscribe on Apple for £4.99: - Full-length and ad-free Intelligence Squared podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series … Already a subscriber? Thank you for supporting our mission to foster honest debate and compelling conversations! Visit intelligencesquared.com to explore all your benefits including ad-free podcasts, exclusive bonus content and early access. … Subscribe to our newsletter here to hear about our latest events, discounts and much more. https://www.intelligencesquared.com/newsletter-signup/ Learn more about your ad choices. Visit podcastchoices.com/adchoices Learn more about your ad choices. Visit podcastchoices.com/adchoices

How can we make decisions under conditions of indeterminacy? Robert Williams discusses this challenging issue with Nigel Warburton.  This episode of the Philosophy Bites podcast has been made in association with Vagueness & Ethics, a research project funded by the European Commission (grant agreement number 101028625 — H2020-MSCA-IF-2020) and led by Miguel Dos Santos at Uppsala University.

​Sometimes, there is vagueness about whether it is morally permissible (or even in some situations required) to perform a certain act—moral vagueness. What is the source of moral vagueness? Ofra Magidor discusses this topic with Nigel Warburton. This episode of the Philosophy Bites podcast has been made in association with Vagueness & Ethics, a research project funded by the European Commission (grant agreement number 101028625 — H2020-MSCA-IF-2020) and led by Miguel Dos Santos at Uppsala University.